Yayın:
Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction

dc.contributor.authorHazini, Ahmet
dc.contributor.authorCemek, Mustafa
dc.contributor.authorIsildak, Ibrahim
dc.contributor.authorAlpdagtas, Saadet
dc.contributor.authorOnul, Abdullah
dc.contributor.authorSenel, Unal
dc.contributor.authorKocaman, Tuba
dc.contributor.authorDur, Ali
dc.contributor.authorIraz, Mustafa
dc.contributor.authorUyarel, Huseyin
dc.date.accessioned2026-06-27T13:43:26Z
dc.date.issued2015
dc.description.abstractIntroduction: Acute myocardial infarction (AMI) is still one of the most common causes of death worldwide. In recent years, for diagnosis of myocardial ischemia, a new parameter, called ischemia modified albumin (IMA), which is thought to be more advantageous than common methods, has been researched. Aim: In this study, systematic analysis of parameters considered to be related to myocardial ischemia has been performed, comparing between control and myocardial ischemia groups. Material and methods: We selected 40 patients with AMI and 25 healthy controls for this study. Ischemia modified albumin levels, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) antioxidant enzyme activities and non-enzymatic antioxidants such as retinol, alpha-tocopherol, beta-carotene and ascorbic acid levels were investigated in both groups. Glutathione (GSH) and malondialdehyde (MDA) levels, which are indicators of oxidative stress, were compared between patient and control groups. Results: Ischemia modified albumin levels were found significantly higher in the AMI diagnosed group when compared with controls. The MDA level was elevated in the patient group, whereas the GSH level was decreased. SOD, GPx and CAT enzyme levels were decreased in the patient group, where it could be presumed that oxidative stress causes the cardiovascular diseases. Conclusions: Due to the increased oxidative stress, non-enzymatic and enzymatic antioxidant capacity was affected. Systematic investigation of parameters related to myocardial infarction has been performed, and it is believed that such parameters can contribute to protection and early diagnosis of AMI and understanding the mechanism of development of the disease.en
dc.description.sponsorshipScientific and Technological Research Council of Turkey [TUBITAK-SBAG-112S166]
dc.description.sponsorshipYildiz Technical University [2013-07-04-YL07]
dc.description.urihttps://doi.org/10.5114/pwki.2015.55600
dc.identifier.doi10.5114/pwki.2015.55600
dc.identifier.eissn1897-4295
dc.identifier.endpage303
dc.identifier.issn1734-9338
dc.identifier.issue4
dc.identifier.pubmed26677379
dc.identifier.startpage298
dc.identifier.urihttps://hdl.handle.net/20.500.14981/54496
dc.identifier.volume11
dc.identifier.wos000365247700005
dc.language.isoeng
dc.publisherTERMEDIA PUBLISHING HOUSE LTD
dc.relation.ispartofPOSTEPY W KARDIOLOGII INTERWENCYJNEJ
dc.rightsopenAccess
dc.subjectmyocardial infarction
dc.subjectischemia modified albumin
dc.subjectoxidative stress
dc.subjectenzymatic and non-enzymatic antioxidants
dc.subjectREPERFUSION INJURY
dc.subjectGLUTATHIONE
dc.subjectDISEASE
dc.subjectDAMAGE
dc.subjectASSAY
dc.subjectCardiovascular System & Cardiology
dc.titleInvestigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar